Howard C. Birndorf - Nov 14, 2022 Form 4 Insider Report for Adamis Pharmaceuticals Corp (ADMP)

Role
Director
Signature
/s/ David J. Marguglio, as attorney-in-fact for Howard C. Birndorf
Stock symbol
ADMP
Transactions as of
Nov 14, 2022
Transactions value $
$0
Form type
4
Date filed
11/16/2022, 03:41 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMP Warrant to Purchase Common Stock Disposed to Issuer -58.8K -100% 0 Nov 14, 2022 Common Stock 58.8K $8.50 Direct F1
transaction ADMP Warrant to Purchase Common Stock Award +58.8K 58.8K Nov 14, 2022 Common Stock 58.8K $8.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The two reported transactions involved an amendment to extend the term of an outstanding investor warrant originally issued on November 15, 2007.